ETF Exchange > ARCX:IDNA ETF
ARCX:IDNA - ETF Fact Sheet
iShares Genomics Immunology and Healthcare ETF - USD
Fund Identification
Ticker
ARCX:IDNA
ISIN
US46435U1925
Main Metrics
Price
$32.85Expense Ratio
0.47%AuM
$193.84MTracking Difference
-0.91%Ratings
Trackinsight rating
★★★★★Official Investment Strategy
The iShares Genomics Immunology and Healthcare ETF seeks to track the investment results of an index composed of developed and emerging market companies that could benefit from the long-term growth and innovation in genomics, immunology, and bioengineering.
ARCX:IDNA's historical prices, performance, and flows
1m returns
10%
1m flows
$13M
* Net total returns
All data as of 17 July 2026
The ETF Exchange is brought to you by
With data and analysis by
See all ARCX:IDNA data with a
free P&I Online account
free P&I Online account
Enjoy unlimited ETF searches and access to tear-sheets of over 4,000 North-American funds.
or Login
ARCX:IDNA's characteristics
Manager
Manager statistics
1787 funds, $6,329.73Bn in AUM
Benchmark
NYSE FactSet Global Genomics and Immuno Biopharma Index NTR - USD
Replication method
Direct (Physical)
Asset class
Equity
Dividend policy
Distributing
ARCX:IDNA's exposure
Countries
USA
59.80%
France
8.62%
Germany
7.84%
Other
23.74%
Sectors
Healthcare
99.91%
Top 5 holdings
Revolution Medicines, Inc.
7.38%
Moderna, Inc.
6.36%
Ipsen SA
4.80%
Merck & Co., Inc.
4.44%
Twist Bioscience Corp.
4.27%
Total holdings
50
Total weight of top 5
27.25%
